Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
260
-
Total 13F shares, excl. options
-
78.8M
-
Shares change
-
+1.1M
-
Total reported value, excl. options
-
$4.03B
-
Value change
-
+$67.6M
-
Put/Call ratio
-
0.7
-
Number of buys
-
133
-
Number of sells
-
-117
-
Price
-
$50.96
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q1 2025
296 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q1 2025.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 260 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.8M shares
of 79.2M outstanding shares and own 99.44% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.61M shares), BlackRock, Inc. (7.77M shares), RTW INVESTMENTS, LP (7.48M shares), ARMISTICE CAPITAL, LLC (5.43M shares), WELLINGTON MANAGEMENT GROUP LLP (5.42M shares), JANUS HENDERSON GROUP PLC (2.92M shares), TORONTO DOMINION BANK (2.61M shares), STATE STREET CORP (2.45M shares), FMR LLC (2.01M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.87M shares).
This table shows the top 260 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.